Navigation Links
DBT And IAVI Forge Partnership To Develop Next Generation Vaccine Candidates

The Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India and the International AIDS Vaccine Initiative signed an agreement today to address a major obstacle in AIDS vaccine development: the design of candidate vaccines to elicit neutralizing antibodies against HIV. A new Indian Medicinal Chemistry Programme, co-sponsored and co-funded by IAVI and the Department of Biotechnology, will comprise top Indian and U.S. scientists tasked with accelerating the pace of AIDS vaccine discovery and developing creative concepts for the next generation of AIDS vaccines.

Union Minister for Science and Technology and Earth Sciences Shri. Kapil Sibal said that vaccine research is so critical that the Health Ministry and the Science and Technology Ministry have joined hands to provide the effort the support it needs.

Indias Department of Biotechnology is delighted to be a part of the global search for an efficacious AIDS vaccine. This was stated by Dr. Maharaj K. Bhan, Secretary, DBT. He said only through these kinds of biotechnology ventures involving international collaborations and the sharing of scientific knowledge, can we hope to solve the complex biomedical problems of our times.

According to Seth Berkley, CEO and President of IAVI, this new partnership will broaden ongoing efforts in India to find an AIDS vaccine.

The Indian Programme will complement the work of IAVIs Neutralizing Antibody Consortium (NAC), a team of internationally recognized scientists working on the neutralizing antibody challenge. Researchers believe an ideal AIDS vaccine must evoke an antibody response that can block HIV from entering healthy cells, as well as reduce the amount of viral dissemination through a cell-mediated immune response to HIV-infected cells. Yet today, virtually all current vaccine candidates in the pipeline are based on cell-mediated immune responses alone, failing to target the second cr
'"/>




Page: 1 2 3

Related medicine news :

1. Never Forget Brushing And Flossing
2. Forgetful? You May Be Losing More Than Just Your Memory
3. When Your Pet Forgets Who You Are
4. Forge Ahead On Folate Fortification
5. Chemo Brain- Nothing Forgettable About It
6. DBT And IAVI Forge Partnership To Develop “Next Generation” Vaccine Candidats
7. Forgetfulness Actually Helps Your Brain Stay Healthy
8. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
9. Partnership Between Diabetes India And Elsevier Announced
10. Betterment Of Health In Case Of Gay And Lesbian Civil Partnerships
11. Private Public Partnership To Tackle TB, In Karnataka
Post Your Comments:
(Date:12/2/2008)...EAK to collect and disseminate pharmacy experience...ue, Wash. (PRWEB) December 2, 2008 -- Pharmacy On... initiative to focus public and industry attention...ck-off of SPEAK will occur during the American Soc...ear Clinical Meeting, to be held December 7-11 in ...
(Date:12/2/2008)... this year,s ASHP midyear meeting, FFF Enterprises...r of critical-care biopharmaceuticals and vaccines...chain integrity and demonstrate how the company ha.... (Booth #1439) , (Vocus)...eeting, FFF Enterprises, the nation,s largest and ...
(Date:12/2/2008)... the International Day of Disabled Persons is reco...story of a young boy born with backwards pointing ...y, a floating hospital docked in Liberia, Benedict...with the other children his age. High resolution...hipsnewsroom.org , Garde...
(Date:12/2/2008)...ar Unafraid: Learning to Trust No Matter What by J...2008 Awards.,In 1977, strange symptoms assaulted ... with multiple sclerosis. Jo had backpacked up 14,...ty miles an hour. , Battl...raid: Learning to Trust No Matter What by Jo Franz...
Breaking Medicine News(10 mins):Health News:Pharmacy OneSource Launches SPEAK Initiative to Promote Medication Safety Awareness 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 3Health News:Mercy Ships Recognizes International Day of Disabled Persons 2Health News:Mercy Ships Recognizes International Day of Disabled Persons 3Health News:Nothing Has Stopped This Woman--MS, Divorce, Abuse, Trauma--How to Live Adventurously and Fearlessly No Matter What Happens 2Health News:Nothing Has Stopped This Woman--MS, Divorce, Abuse, Trauma--How to Live Adventurously and Fearlessly No Matter What Happens 3
...ttent treatment with sulfadoxine-pyrimethamine, a ... in treating malaria in Mozambican children //by R...edro Alonso, coordinator of the Centre of Internat... findings of their study are to be published in th...
...e backdrop of questions being raised about its aut...of making the All India Institute of Medical Scien...ies". "We hope we can come out with some recommen...e as possible from authorities," M S Valiathan, wh...
... live alone are twice as likely to have serious he...s a new study//. According to a study published in... Danish researchers surveyed around 1,38,000 adult... in one area of Denmark and found that certain hea...
...n reported that doctors from the Michigan State Un...treatment plan, which allows a more effective// me...r people suffering from symptoms and conditions th...Smith, a physician and professor in MSU’s Departme...
Other Medicine News:Health News:Intermittent Treatment Found Effective In Malaria 2Health News:Intermittent Treatment Found Effective In Malaria 3Health News:Intermittent Treatment Found Effective In Malaria 4Health News:Intermittent Treatment Found Effective In Malaria 5Health News:Revolutionary New Treatment Plan Developed For Treatment Of Unexplained Symptoms 2
(Date:11/25/2008)...Nov. 25 Proteolix, Inc., a,leader...utics that target,protein degradation pathways in...that data from two ongoing Phase 2 clinical trials...nted at the upcoming 50th Annual Meeting of the,A...is the first in a new class,of specific proteasom...
(Date:11/25/2008)...ical Trial to Assess Survival of Patients Receivin...ectable Hepatocellular Carcinoma , , BELLEV...Oncology, Inc. (LSO) today announced the completio... of Light Infusion Therapy(TM) (Litx(TM)) as a tre...HCC), also known as hepatoma or primary liver canc...
(Date:11/24/2008)...Newswire/ -- Domino,s Pizza (NYSE: DPZ ), the,r...ng up to raise dough for,the kids of St. Jude Chi...,Thanks and Giving campaign. Domino,s customers wi...nt of purchase to benefit the children of St. Jude...one or when ordering online at, www.dominos.com ....
(Date:11/24/2008)...ion leadership and long-term commitment to hepatit...PRNewswire-FirstCall/ -- Schering-Plough Corporati... on boceprevir, its lead investigational oral hepa...development. The company believes boceprevir has ...lass protease inhibitor for treating chronic hepat...
Breaking Medicine Technology:Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9Gene Mutation Puts Some Kids at Risk for Tobacco Addiction 24151 1Gene Mutation Puts Some Kids at Risk for Tobacco Addiction 24151 2U S Health Care Still Ill Survey Finds 24149 1U S Health Care Still Ill Survey Finds 24149 2U S Health Care Still Ill Survey Finds 24149 3Aethons Train Themed Delivery Robot Available To Childrens Hospitals Nationwide 24147 1Aethons Train Themed Delivery Robot Available To Childrens Hospitals Nationwide 24147 2WeissComm Partners Ranks Among Top 5 Best U S Midsize PR Agencies to Work For 24145 1WeissComm Partners Ranks Among Top 5 Best U S Midsize PR Agencies to Work For 24145 2
Basic ergonomic chairs with concave seats and standard-sized backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • BTN/1Q-CAB chairs are
Basic ergonomic chairs with concave seats and standard-sized backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • BTN/1Q-CAB chairs are
Basic ergonomic chairs with concave seats and standard-sized backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • BTN/1Q-CAB chairs are
Basic ergonomic chairs with concave seats and standard-sized backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • BTN/1Q-CAB chairs are
Medicine Products: